Advanced PET Imaging, Nuclear Medicine, and Therapy: From Diagnostics to Theranostics on October 22-23, 2026 in Las Vegas, United States

This course provides a clinical perspective of PET/CT imaging and the emerging use of Theranostic agents within Nuclear Medicine. A broad perspective on the economic, clinical, and academic aspects of the latest trends in PET/CT imaging and Nuclear Medicine therapy will be presented.

At the conclusion of this course, participants will be able to:

- Describe new developments in the merger of diagnostic and therapeutic radioligands for PET/CT imaging and therapy with specific focus on DOTA, PSMA, and PRRT

- Describe the logistics of bringing these new diagnostic and therapeutic technologies to clinical practice

- Identify the key clinical indications for new emerging tracers for Neuroendocrine Tumor and Prostate cancer using somatostatin receptor and PSMA PET/CT imaging

- Review and discuss the standard-of-care clinical application and advanced interpretation of FDG PET/CT

URLs:

Tickets: https://go.evvnt.com/3669339-2?pid=10008

Virtual: https://go.evvnt.com/3669339-3?pid=10008

Time: 7:30 AM - 4:45 PM

Prices:

Standard Registration-Physicians MD/DO: USD 1495.00,

Nurses/Advanced Practice Professionals/Retired/Active Military: USD 1395.00,

Radiologic Technologists/Residents/Fellows: USD 1295.00

Speakers: Phillip Kuo, MD, PhD, FACR, Don C. Yoo, MD